COSMOS HEALTH INC (COSM) Stock News

USA - NASDAQ:COSM - US2214133058 - Common Stock

0.8101 USD

-0.09 (-10.01%)

Last: 10/31/2025, 8:00:01 PM

0.835 USD

+0.02 (+3.07%)

After Hours: 10/31/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

COSM Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Cosmos Health Inc.

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

a day ago - By: Cosmos Health Inc.

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

11 days ago - By: Cosmos Health Inc.

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

11 days ago - By: Cosmos Health Inc.

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

17 days ago - By: Cosmos Health Inc.

Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement

19 days ago - By: Cosmos Health Inc.

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

19 days ago - By: Cosmos Health Inc.

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

23 days ago - By: Cosmos Health Inc.

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

23 days ago - By: Cosmos Health Inc.

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

a month ago - By: Benzinga - Mentions: IVA ABP ONMD VTVT ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

a month ago - By: Benzinga - Mentions: PRPH ABP WORX TRVI ...

12 Health Care Stocks Moving In Friday's After-Market Session

a month ago - By: Cosmos Health Inc.

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

a month ago - By: Cosmos Health Inc.

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

a month ago - By: Cosmos Health Inc.

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

a month ago - By: Cosmos Health Inc.

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

a month ago - By: Cosmos Health Inc.

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

a month ago - By: Cosmos Health Inc.

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

a month ago - By: Cosmos Health Inc.

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

2 months ago - By: Cosmos Health Inc.

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

2 months ago - By: Cosmos Health Inc.

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

3 months ago - By: Cosmos Health Inc.

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

3 months ago - By: Cosmos Health Inc.

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

3 months ago - By: Cosmos Health Inc.

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

3 months ago - By: Cosmos Health Inc.

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

3 months ago - By: Cosmos Health Inc.

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

3 months ago - By: Cosmos Health Inc.

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

4 months ago - By: Yahoo Finance - Mentions: MSFT

Cosmos Health enters U.S. market with DolCas Biotech agreement

4 months ago - By: Cosmos Health Inc.

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

4 months ago - By: Cosmos Health Inc.

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

6 months ago - By: Cosmos Health Inc.

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

6 months ago - By: Cosmos Health Inc.

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

6 months ago - By: Cosmos Health Inc.

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

6 months ago - By: Cosmos Health Inc.

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

6 months ago - By: Cosmos Health Inc.

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units